Sign up for the QMED & MD+DI Daily newsletter.
Consumer Group Wants J&J Birth-Control Patch Pulled
Public Citizen's Health Research Group is asking FDA to force the Ortho-Evra birth-control patch, made by Johnson & Johnson, off the market, Reuters reports. A study released in January found that women aged 18-44 who use the patch are twice as likely to develop a dangerous kind of blood blot than women on birth-control pills.
May 8, 2008
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "Consumer Group Wants J&J Birth-Control Patch Pulled")
Public Citizen is also concerned that the amount of estrogen released by the patch varies widely among individual women -- and estrogen is linked to blood clots.FDA has said that the risk of the patch causing a blood clot is low, and therefore the product is still considered to be safe and effective when used as directed. It said that for every 10,000 women who use a hormonal contraceptive for one year, 3-5 will develop a blood clot.
You May Also Like
.png?width=700&auto=webp&quality=80&disable=upscale)
.png?width=700&auto=webp&quality=80&disable=upscale)